Something Ventured: Vor Biopharma and 3 other startups got venture funding a year ago. Did it help them do what they said it would?

first_img By Kate Sheridan March 2, 2020 Reprints Something Ventured: Vor Biopharma and 3 other startups got venture funding a year ago. Did it help them do what they said it would? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Hyacinth Empinado/STAT General Assignment Reporter Kate covers biotech startups and the venture capital firms that back them. Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. GET STARTED This story is part of STAT’s quarterly series Something Ventured, which looks at early-stage startups. You can read the earlier stories in the series here. Every quarter, the CEO of a public biotech company can expect to spend an hour or two on the phone, describing her company’s progress to shareholders and reporters and answering questions from analysts. @sheridan_kate [email protected] center_img About the Author Reprints Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Something Ventured Kate Sheridan Log In | Learn More What’s included? What is it? Tags biotechnologyBostonfinanceSTAT+last_img read more